| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | -0.052 | 0.08 |
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.08 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.065 | 0.08 |
| mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | 0.13 | 0.08 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.08 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | -0.14 | 0.08 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.058 | 0.09 |
| mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.09 |
| mRNA | StemRegenin 1 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.09 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.09 |